Xpect Giardia Lateral Flow Assay, Model 2450020
FDA 510(k) K031942 · Remel, Inc.
510(k) numberK031942
Submission
- Device name
- Xpect Giardia Lateral Flow Assay, Model 2450020
- Applicant
- Remel, Inc.
Ramsey, MN, US - Received
- June 24, 2003
- Decision date
- November 18, 2003
- Decision
- Substantially Equivalent (SESE)
- Type
- Traditional 510(k)
- Summary
- 510(k) summary available from FDA
Device classification
- Product code
- MHI – Giardia Spp.
- Device class
- Class II (moderate risk)
- Regulation
- 21 CFR 866.3220
- Specialty
- Microbiology
Other 510(k)s with product code MHI
| 510(k) | Device | Applicant | Decision |
|---|---|---|---|
| K120001 | Unigold GiardiaMHI · Traditional | Trinity Biotech | 03/01/2013SE |
| K103673 | Giardia/ Cryptosporidium Quik ChekMHI · Traditional | Techlab Inc., Corporate Research Center | 08/18/2011SE |
| K081064 | Giardia Fecal Antigen Detection Lateral Flow Kit, Model Gl-LfMHI · Traditional | Ivd Research, Inc. | 01/14/2009SE |
| K031834 | Xpect Giardia/Cryptosporidium Lateral Flow AssayMHI · Traditional | Remel, Inc. | 11/10/2003SE |
| K033274 | Giardia IIMHI · Special | Techlab, Inc. | 11/04/2003SE |
| K024113 | IVD Crypto/Giardia DfaMHI · Traditional | Ivd Research, Inc. | 03/05/2003SE |
| K020583 | IVD Giardia Antigen Detection Assay Model GL-96MHI · Traditional | Ivd Research, Inc. | 09/17/2002SE |
| K983399 | Giardia/Cryptosporidium Combo Rapid AssayMHI · Traditional | Genzyme Diagnostics | 01/11/1999SE |
| K982711 | Premier GiardiaMHI · Traditional | Meridian Diagnostics, Inc. | 11/25/1998SE |
| K982245 | Triage,Parasite Panel, Triage Cryptosporidium and Entamoeba Histolytica, Triage…MHI · Traditional | Biosite Incorporated | 10/06/1998SE |
More from Biosite Incorporated
| 510(k) | Device | Decision |
|---|---|---|
| K162620 | Remel Spectra ESBLJSO · Traditional | 05/01/2017SE |
| K131804 | Remel Xpect Flu A&BGNX · Special | 07/12/2013SE |
| K092407 | Remel Spectra MrsaJSO · Traditional | 10/08/2010SE |
| K072827 | Rpmi 1640 Agar W/Mops and 2% GlucoseMJE · Traditional | 11/26/2007SE |
| K041951 | Xpect Clostridium Difficile Toxin A/BLLH · Traditional | 11/15/2004SE |
| K033479 | Prospect Clostridium Difficile Toxin A/B Microplate AssayLLH · Traditional | 02/26/2004SE |
| K031965 | Xpect Cryptosporidium Lateral Flow Assay, Model 2451020MHJ · Traditional | 11/14/2003SE |
| K031834 | Xpect Giardia/Cryptosporidium Lateral Flow AssayMHI · Traditional | 11/10/2003SE |
| K031565 | Xpect Influenza A/BPSZ · Traditional | 07/17/2003SE |
| K013711 | Bacti-Swab DryLIO · Traditional | 11/26/2001SE |
Questions and answers
When was Xpect Giardia Lateral Flow Assay, Model 2450020 cleared by the FDA?
Xpect Giardia Lateral Flow Assay, Model 2450020 (K031942) received a 510(k) decision of Substantially Equivalent on November 18, 2003, 147 days after the submission was received.
What is the product code of K031942?
The FDA product code is MHI – Giardia Spp., a Class II (moderate risk) device regulated under 21 CFR 866.3220.